Corcept Therapeutics Incorporated · NASDAQ:CORT

Vieira Roberto Wandenkolk sold 296 Corcept Therapeutics Incorporated shares (Form 4)

Traded Sep 16, 2026 · Filed Sep 18, 2026

On Sep 16, 2026, Vieira Roberto Wandenkolk (President, Oncology) sold 296 Corcept Therapeutics Incorporated shares at US$100.82 for US$29,843 under a trading plan, leaving 3,946 shares. Filed Sep 18, 2026 (Form 4).

Sold
296 shares
Price
US$100.82
Value
US$29,843
Holding after
3,946 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President, Oncology

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 16, 2026Common StockSale296US$100.823,946Direct

Source

View original at SEC

Related